rdf:type |
|
lifeskim:mentions |
umls-concept:C0003962,
umls-concept:C0004083,
umls-concept:C0005767,
umls-concept:C0024264,
umls-concept:C0027651,
umls-concept:C0030705,
umls-concept:C0032207,
umls-concept:C0108779,
umls-concept:C0205409,
umls-concept:C0683598,
umls-concept:C0750502,
umls-concept:C0882903,
umls-concept:C1140680,
umls-concept:C1705241,
umls-concept:C1705242,
umls-concept:C1707455
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-6-18
|
pubmed:abstractText |
Tumor infiltrating lymphocytes (TILs) and T regulatory cells (Tregs) have been associated with prognosis in ovarian cancer, but their prognostic significance in ascites has not been studied. We performed a prospective study of T lymphocytes isolated from ascites from patients with ovarian carcinoma and we compared them with the respective populations in blood and tumors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0090-8258
|
pubmed:author |
pubmed-author:AntsaklisAA,
pubmed-author:ArchimandritisAA,
pubmed-author:BamiaCC,
pubmed-author:BamiasAA,
pubmed-author:DimopoulosM AMA,
pubmed-author:KafantariEE,
pubmed-author:LiakouCC,
pubmed-author:PapageorgiouTT,
pubmed-author:PapatheodoridisGG,
pubmed-author:PolitiEkE,
pubmed-author:RodolakisAA,
pubmed-author:TsiatasM LML,
pubmed-author:TsitsilonisOO,
pubmed-author:VlahovBB,
pubmed-author:VoulgarisZZ
|
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75-81
|
pubmed:meshHeading |
pubmed-meshheading:17433425-Adult,
pubmed-meshheading:17433425-Aged,
pubmed-meshheading:17433425-Aged, 80 and over,
pubmed-meshheading:17433425-Antigens, CD3,
pubmed-meshheading:17433425-Antigens, CD56,
pubmed-meshheading:17433425-Ascites,
pubmed-meshheading:17433425-Drug Resistance, Neoplasm,
pubmed-meshheading:17433425-Female,
pubmed-meshheading:17433425-Flow Cytometry,
pubmed-meshheading:17433425-Humans,
pubmed-meshheading:17433425-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:17433425-Killer Cells, Natural,
pubmed-meshheading:17433425-Middle Aged,
pubmed-meshheading:17433425-Neoplasm Staging,
pubmed-meshheading:17433425-Organoplatinum Compounds,
pubmed-meshheading:17433425-Ovarian Neoplasms,
pubmed-meshheading:17433425-T-Lymphocytes, Regulatory
|
pubmed:year |
2007
|
pubmed:articleTitle |
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens, Greece. abamias@med.uoa.gr <abamias@med.uoa.gr>
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|